PROPRANOLOL HYDROCHLORIDE (propranolol hydrochloride) by Agepha Pharma is mechanism of action the mechanism of the antihypertensive effect of propranolol has not been established. Approved for common migraine headache, the management of hypertension, the management of hypertensive emergencies and 2 more indications. First approved in 2020.
Drug data last refreshed 23h ago
Mechanism of Action The mechanism of the antihypertensive effect of propranolol has not been established. Among the factors that may be involved in contributing to the antihypertensive action include: (1) decreased cardiac output, (2) inhibition of renin release by the kidneys, and (3) diminution…
Worked on PROPRANOLOL HYDROCHLORIDE at Agepha Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Propranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung Cancer